Fig. 7From: Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patientsA The TIDE score for PC patients showing in the LAMB3hi and LAMB3low groups. B The TIDE score for PC patients showing in the FN1hi and FN1low groups. C The TIDE score for PC patients showing in the KRT19hi and KRT19low groups. D The TIDE score for PC patients showing in the ANXA1hi and ANXA1low groups. E The mRNA expression of immune checkpoints for PC patients showing in the FN1hi and FN1low groups. F The mRNA expression of immune checkpoints for PC patients showing in the ANXA1hi and ANXA1low groupsBack to article page